Published

Psilocybin in neuropsychiatry: a review of its pharmacology, safety, and efficacy.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: CNS spectrums
Date: 2023-08-01
Source: PubMed
DOI: 10.1017/s1092852922000888
PubMed: 35811423

Authors

Dodd S Norman TR Eyre HA Stahl SM Phillips A Carvalho AF Berk M

Watch author

Derived topics and classifications

psilocybin psilocin Depression Anxiety PTSD Pharmacology Mechanism of Action Receptor Pharmacology Review Article Safety Adverse Events Review Article

Citation graph

0 referenced DOIs found in stored source metadata. 8 indexed papers cite this DOI.

Open citation network

Indexed papers citing this DOI

Quantifying psilocybin exposure in a natural product-based retreat setting: An observational field method for dose measurement2026-12-01 In-silico toxicity study of tryptamine, psilocin, psilocybin, N,N-dimethyltryptamine, 5’-methoxy-N,N-dimethyltryptamine and O-acetylpsilocin2026-08-01 DESI-MSI-Based Multi-Organ Distribution Mapping of Psilocin in Zebrafish2026-06-18 Effect of psilocybin-assisted psychotherapy on anxiety symptoms: A systematic review and meta-analysis2026-05-29 Design, Synthesis, and Pharmacokinetic Profiling of Fluorinated Reversible N -Alkyl Carbamate Derivatives of Psilocin for Sub-Hallucinogenic Brain Exposure2026-02-12 Effects of Psilocin and Psilocybin on Human 5-HT4 Serotonin and H2 Histamine Receptors in Perfused Hearts of Transgenic Mice2025-07-06 Psilocin, A Psychedelic Drug, Exerts Anticonvulsant Effects Against PTZ- and MES-Induced Seizures in Mice via 5-HT1A and CB1 Receptors: Involvement of Nitrergic, Opioidergic, and Kynurenine Pathways2025-04-01 Psilocybin in neuropsychiatry: a review of its pharmacology, safety, and efficacy.2023-08-01

Related papers

From Trials to Clinics: Considerations for Implementing Psychedelic-Assisted Therapy Into Clinical PracticePharmacology Research & Perspectives · 2026-05-10 Editorial: Psychedelic substances and neurological diseases: from basics to clinical applicationFrontiers in Pharmacology · 2026-03-15 Therapeutic Potential of Classical Psychedelics and NonHallucinogenic Psychoplastogens in Psychiatric DisordersPsychiatry and Clinical Psychopharmacology · 2026-03-30 Novel perspectives for glutamatergic strategies, psychedelics and antipsychotic augmentation in Treatment Resistant Depression: A narrative reviewClinical Neuropsychopharmacology and Addiction · 2025-09-24 Psilocybin-induced neurocardiogenic syncope: a case reportPsychopharmacology · 2026-05-28 Announcement of special issue: ‘Behavioural pharmacology of ketamine and psychedelic drugs’Behavioural Pharmacology · 2026-05-06 Psychedelics, entactogens and psychoplastogens for depression and related disorders.British journal of pharmacology · 2026-07-01 Exploring new avenues: Psychedelic-assisted therapy for young people.British journal of clinical pharmacology · 2026-05-08